| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 |
| filingDate |
2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30e34f97ee24ce287a0bb3e6f11a265b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b0caa50150c04fa16662f91a791fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5690a6af6c1cfeea6b30111a7cd77847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82855acb6b766fd4457f63e4ae21a226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24239ba65d77b0f502597192ebe48e1b |
| publicationDate |
2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9115120-B2 |
| titleOfInvention |
Heterocyclic modulators of HIF activity for treatment of disease |
| abstract |
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208059-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10450269-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10888554-B2 |
| priorityDate |
2012-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |